Published in AIDS Weekly, July 22nd, 2002
The private placement was concluded directly by MedMira in reliance upon applicable securities exemptions. The 2,500,000 common shares issued are subject to a 4-month hold period.
"MedMira is poised to capture short-term profitability and long term success," said Stephen Sham, chairman and CEO of MedMira. "The results...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.